The information on the Delegated Act on Safety Features for Medicinal Products for Human Use can be found here.
The form for the nomination of the representatives can be found here.
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions